Treatment of Chronic Non-A, Non-B Hepatitis with Recombinant Human Alpha Interferon
- 18 December 1986
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 315 (25), 1575-1578
- https://doi.org/10.1056/nejm198612183152503
Abstract
We treated 10 patients who had chronic non-A, non-B hepatitis with recombinant human alpha interferon in varying doses (0.5 to 5 million units) daily, every other day, or three times weekly for up to 12 months.This publication has 15 references indexed in Scilit:
- Serological tests for non-A, non-B hepatitis: ControversyLiver International, 2008
- TREATMENT OF CHRONIC HEPATITIS DUE TO HEPATITIS B VIRUSThe Lancet, 1985
- Recombinant Leukocyte Interferon Treatment of Chronic Hepatitis BHepatology, 1985
- Sporadic Non-A, Non-B Hepatitis: Frequency and Epidemiology in an Urban U.S. PopulationThe Journal of Infectious Diseases, 1982
- Long-term follow-up of acute and chronic non-A, non-B post-transfusion hepatitis: evidence of progression to liver cirrhosis.Gut, 1982
- Donor transaminase and recipient hepatitis. Impact on blood transfusion servicesJAMA, 1981
- Antiviral Treatment of Chronic Hepatitis B Virus Infection. I. Changes in Viral Markers with Interferon Combined with Adenine ArabinosideThe Journal of Infectious Diseases, 1981
- Serum Alanine Aminotransferase of Donors in Relation to the Risk of Non-A,Non-B Hepatitis in RecipientsNew England Journal of Medicine, 1981
- The long-term course of non-A, non-B post-transfusion hepatitisGastroenterology, 1980
- The Chronic Sequelae of Non-A, Non-B HepatitisAnnals of Internal Medicine, 1979